文献速递重症综合管理与镇静镇痛

成人重症监护病房抗生素给药与监测的国际调查

International survey of antibiotic dosing and monitoring in adult intensive care units.
PubMed 文献 · Crit Care · 2023-06-19
一句话结论国际调查显示:β-内酰胺类更多采用延长输注,万古霉素、氨基糖苷类治疗药物监测使用率增高,但给药软件使用仍少。

该研究为横断面国际调查,通过专业学会和网络发放,旨在描述自ADMIN-ICU 2015调查以来重症患者抗生素给药、给药方式和监测实践的变化。共纳入来自45个国家409家医院的538名受访者(71%医生,29%药师),调查万古霉素、哌拉西林/他唑巴坦、美罗培南和氨基糖苷类的给药与监测实践。结果显示万古霉素多采用间歇输注,74%受访者使用负荷剂量,间歇输注和连续输注最常用负荷剂量分别为25 mg/kg和20 mg/kg;哌拉西林/他唑巴坦和美罗培南最常采用延长输注(分别为42%和51%);万古霉素、氨基糖苷类、哌拉西林/他唑巴坦和美罗培南的治疗药物监测使用率分别为90%、82%、43%和39%,高收入国家更常进行;给药软件使用罕见,最常用于万古霉素(11%)。作者结论认为自ADMIN-ICU 2015调查以来实践出现诸多变化,β-内酰胺类更常采用延长输注,治疗药物监测使用增加,与新兴证据一致。

要点

  • 万古霉素多采用间歇输注,74%受访者使用负荷剂量,间歇输注和连续输注最常用负荷剂量分别为25 mg/kg和20 mg/kg。
  • 哌拉西林/他唑巴坦和美罗培南最常采用延长输注,分别占42%和51%。
  • 治疗药物监测使用率:万古霉素90%、氨基糖苷类82%、哌拉西林/他唑巴坦43%、美罗培南39%,高收入国家更常进行。
  • 给药软件在临床实践中罕见使用,最常用于万古霉素(11%)。
  • 作者结论认为自ADMIN-ICU 2015调查以来,β-内酰胺类更常采用延长输注,治疗药物监测使用增加,与新兴证据一致。

适用人群与场景

  • 成人重症监护病房中接受万古霉素、哌拉西林/他唑巴坦、美罗培南或氨基糖苷类治疗的患者。

处置流程与药物剂量

  • 万古霉素多采用间歇输注;74%受访者使用负荷剂量,间歇输注最常用负荷剂量为25 mg/kg,连续输注最常用负荷剂量为20 mg/kg。
  • 哌拉西林/他唑巴坦和美罗培南最常采用延长输注,分别占42%和51%。
  • 治疗药物监测使用率:万古霉素90%、氨基糖苷类82%、哌拉西林/他唑巴坦43%、美罗培南39%,高收入国家更常进行。
  • 给药软件在临床实践中罕见使用,最常用于万古霉素(11%)。

研究设计与关键结果

  • 研究类型为横断面国际调查,通过专业学会和网络发放,共538名受访者(71%医生,29%药师)来自45个国家409家医院完成调查。
  • 万古霉素多采用间歇输注,74%受访者使用负荷剂量,间歇输注和连续输注最常用负荷剂量分别为25 mg/kg和20 mg/kg。
  • 哌拉西林/他唑巴坦和美罗培南最常采用延长输注,分别占42%和51%。
  • 治疗药物监测使用率分别为万古霉素90%、氨基糖苷类82%、哌拉西林/他唑巴坦43%、美罗培南39%,高收入国家更常进行。
  • 给药软件在临床实践中罕见使用,最常用于万古霉素(11%)。

证据类型、等级与局限

  • 证据类型:横断面国际调查。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为自ADMIN-ICU 2015调查以来实践出现诸多变化,β-内酰胺类更常采用延长输注,治疗药物监测使用增加,与新兴证据一致。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In recent years, numerous dosing studies have been conducted to optimize therapeutic antibiotic exposures in patients with serious infections. These studies have led to the inclusion of dose optimization recommendations in international clinical practice guidelines. The last international survey describing dosing, administration and monitoring of commonly prescribed antibiotics for critically ill patients was published in 2015 (ADMIN-ICU 2015). This study aimed to describe the evolution of practice since this time.

METHODS: A cross-sectional international survey distributed through professional societies and networks was used to obtain information on practices used in the dosing, administration and monitoring of vancomycin, piperacillin/tazobactam, meropenem and aminoglycosides.

RESULTS: A total of 538 respondents (71% physicians and 29% pharmacists) from 409 hospitals in 45 countries completed the survey. Vancomycin was mostly administered as an intermittent infusion, and loading doses were used by 74% of respondents with 25 mg/kg and 20 mg/kg the most favoured doses for intermittent and continuous infusions, respectively. Piperacillin/tazobactam and meropenem were most frequently administered as an extended infusion (42% and 51%, respectively). Therapeutic drug monitoring was undertaken by 90%, 82%, 43%, and 39% of respondents for vancomycin, aminoglycosides, piperacillin/tazobactam, and meropenem, respectively, and was more frequently performed in high-income countries. Respondents rarely used dosing software to guide therapy in clinical practice and was most frequently used with vancomycin (11%).

CONCLUSIONS: We observed numerous changes in practice since the ADMIN-ICU 2015 survey was conducted. Beta-lactams are more commonly administered as extended infusions, and therapeutic drug monitoring use has increased, which align with emerging evidence.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Williams PG, Tabah A, Cotta MO, et al. International survey of antibiotic dosing and monitoring in adult intensive care units. Crit Care. 2023. PMID: 37331935. doi:10.1186/s13054-023-04527-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。